Concordia Healthcare to buy Amdipharm Mercury for $3.5 bln
Sept 8 (Reuters) - Concordia Healthcare Corp said it would buy Amdipharm Mercury Ltd from private equity firm Cinven in a deal valued at $3.5 billion.
The deal gives Concordia a portfolio of more than 190 niche pharmaceutical products. (Reporting by Amrutha Penumudi in Bengaluru; Editing by Saumyadeb Chakrabarty)
© Thomson Reuters 2017 All rights reserved.